Pierre-Henri Lefevre

Pierre-Henri Lefevre

Auto-generated profile, based on publicly available information

Pierre-Henri Lefevre

Department of Neuroradiology (C.D., M.M., G.G., P.-H.L., F.C., T.C., F.-L.C., Q.V., V.C.), Centre Hospitalier Universitaire (CHU) Gui de Chauliac, Montpellier, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Radiology
Verified
Journal Article
Closed access
BGBoris Guiu
Boris Guiu
JPJean-Michel Petit
Jean-Michel Petit
VCViolaine Capitan
Violaine Capitan
LALudwig Serge Aho-Glele
Ludwig Serge Aho-Glele
DMDavid MASSON
David MASSON
JCJean-Pierre Cercueil
Jean-Pierre Cercueil
Because intravoxel incoherent motion (IVIM) diffusion-weighted MR imaging parameters are strongly modified in nonalcoholic fatty liver disease, steatosis can act as a potential confounder when IVIM is used to assess diffuse liver disease—especially cirrhosis. PurposeTo compare pure molecular diffusion, D, perfusion-related diffusion, D*, and perfusion fraction, f, determined from diffusion-weighted (DW) magnetic resonance (MR) imaging on the basis of the intravoxel incoherent motion (IVIM) theory in patients with type 2 diabetes with and without liver steatosis.Materials and MethodsThis prospective study was approved by the appropriate ethics committee, and written informed consent was obtained from all patients. Between December 2009 and September 2011, 108 patients with type 2 diabetes (51 men, 57 women; mean age, 50 years) underwent 3.0-T single-voxel point-resolved proton MR spectroscopy of the liver (segment VII) to calculate the liver fat fraction from water (4.76 ppm) and methylene (1.33 ppm) peaks, corrected for T1 and T2 decay. Steatosis was defined as a liver fat fraction of at least 5.56%. DW imaging was performed by using a single-shot echo-planar sequence with 11 b values (0, 5, 15, 25, 35, 50, 100, 200, 400, 600, 800 sec/mm2). Liver D, D*, and f ...

26 July 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
FCF. Cagnazzo
F. Cagnazzo
DCD.T. di Carlo
D.T. di Carlo
MCMatteo Cappucci
Matteo Cappucci
PLP.-H. Lefevre
P.-H. Lefevre
VCV. Costalat
V. Costalat
Paolo PerriniPaolo Perrini
Paolo Perrini
BACKGROUND: The implantation of flow-diverter stents for the treatment of ruptured intracranial aneurysms required further investigation. PURPOSE: Our aim was to analyze the outcomes after flow diversion of ruptured intracranial aneurysms. DATA SOURCES: A systematic search of 3 databases was performed for studies published from 2006 to 2018. STUDY SELECTION: According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we included studies (from 2010 to 2018) reporting acutely ruptured intracranial aneurysms treated with flow diversion. DATA ANALYSIS: Random-effects meta-analysis was used to pool the following: aneurysm occlusion rate, complications, rebleeding, and factors influencing the studied outcomes. DATA SYNTHESIS: We included 20 studies evaluating 223 patients with acutely ruptured intracranial aneurysms treated with flow-diverter stents. Immediate angiographic occlusion was obtained in 32% (29/86; 95% CI, 15.4%–48%; I2 = 79.6%) of aneurysms, whereas long-term complete/near-complete aneurysm occlusion was 88.9% (162/189; 95% CI, 84%–93.5%; I2 = 20.9%) (mean radiologic follow-up of 9.6 months). The treatment-related complication rate was 17.8% (42/223; 95% CI, 11%–24%; I2 = 52.6%). Complications were higher in the posterior circulation (16/72 = 27%; 95% CI, 14%–40%; I2 = 66% versus 18/149 = 11.7%; 95% CI, 7%–16%; I2 = 0%) (P = .004) and after treatment with multiple stents (14/52 = 26%; 95% CI, 14%–45%; I2 = 59%) compared with a single stent (20/141 = 10%; 95% CI, 5%–15%; I2 = 0%) (P = .004). Aneurysm rebleeding after treatment was 4% (5/223; 95% CI, 1.8%–7%; I2 = 0%) and was higher in the first 72 hours. LIMITATIONS: Small and retrospective series. CONCLUSIONS: Flow-diversion treatment of ruptured intracranial aneurysms yields a high rate of long-term angiographic occlusion with a relatively low rate of aneurysm rebleeding. However, treatment is associated with a complication rate of 18%. When coiling or microsurgical clipping are not feasible strategies, anterior circulation ruptured aneurysms can be effectively treated with a flow-diversion technique, minimizing the number of stents deployed. Given the 27% rate of complications, flow diversion for ruptured posterior circulation aneurysms should be considered only in selected cases not amenable to other treatments.

20 December 2019 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
SNSam Ng
Sam Ng
IDImad Derraz
Imad Derraz
JBJulien Boetto
Julien Boetto
CDCyril Dargazanli
Cyril Dargazanli
GPGaëtan Poulen
Gaëtan Poulen
VCVincent Costalat
Vincent Costalat
Background Chronic subdural hematoma (CSDH) is a common condition requiring surgical treatment; however, recurrence occurs in 15% of cases at 1 year. Middle meningeal artery (MMA) embolization has recently emerged as a promising treatment to prevent CSDH recurrence. Objective To investigate the effect of MMA embolization on hematoma volume resorption (HVR) after surgery in symptomatic patients. Methods From April 2018 to October 2018, participants with CSDH requiring surgery were prospectively randomized in a pilot study, and received either surgical treatment alone (ST group) or surgery and adjuvant MMA embolization (ST+MMAE group). The primary outcome was HVR measured on the 3 month CT scan compared with the immediate pre-embolization CT scan. Secondary outcomes were clinical recurrence of CSDH and safety measures. Results 46 patients were randomized and 41 of these achieved a 3 month follow-up . Twenty-one patients received MMA embolization. At 3 months, the HVR from postsurgical level was higher in the ST+MMAE group (mean difference 17.5 mL, 95% CI 3.87 to 31.16 mL; p=0.015). Two participants presented a CSDH recurrence (one in each group). One patient died (ST group). No MMA embolization-related adverse events were reported. Conclusion The addition of MMA embolization to surgery led to an increase in CSDH resorption at 3 months. One recurrence of CSDH was reported in each group, and there were no treatment-related complications.

5 October 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
FCF. Cagnazzo
F. Cagnazzo
DMD. Mantilla
D. Mantilla
PLP.-H. Lefevre
P.-H. Lefevre
CDC. Dargazanli
C. Dargazanli
GGG. Gascou
G. Gascou
VCV. Costalat
V. Costalat
The safety and efficacy of flow-diversion treatment of MCA aneurysms have not been well-established. Our aim was to evaluate angiographic and clinical outcomes after flow diversions for MCA aneurysms. A systematic search of PubMed, MEDLINE, and Embase was performed for studies published from 2008 to May 2017. According to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we selected studies with >5 patients describing angiographic and clinical outcomes after flow-diversion treatment of MCA aneurysms. Random-effects meta-analysis was used to pool the following outcomes: aneurysm occlusion rate, procedure-related complications, rupture rate of treated aneurysms, and occlusion of the jailed branches. Twelve studies evaluating 244 MCA aneurysms were included in this meta-analysis. Complete/near-complete occlusion was obtained in 78.7% (95% CI, 67.8%-89.7%) of aneurysms. The rupture rate of treated aneurysms during follow-up was 0.4% per aneurysm-year. The rate of treatment-related complications was 20.7% (95% CI, 14%-27.5%), and approximately 10% of complications were permanent. The mortality rate was close to 2%. Nearly 10% (95% CI, 4.7%-15.5%) of jailed arteries were occluded during follow-up, whereas 26% (95% CI, 14.4%-37.6%) had slow flow. Rates of symptoms related to occlusion and slow flow were close to 5%. Small and retrospective series could affect the strength of the reported results. Given the not negligible rate of treatment-related complications, flow diversion for MCA aneurysms should be considered an alternative treatment when traditional treatment methods are not feasible. However, when performed in this select treatment group, high rates of aneurysm occlusion and protection against re-rupture can be achieved.

1 December 2017 in Stroke
Verified
Journal Article
Closed access
PDF file
CDCyril Dargazanli
Cyril Dargazanli
CACaroline Arquizan
Caroline Arquizan
BGBenjamin Gory
Benjamin Gory
ACArturo Consoli
Arturo Consoli
JLJulien Labreuche
Julien Labreuche
PGPierre-Yves Garcia
Pierre-Yves Garcia
Background and Purpose—Proximal large vessel occlusion (LVO) is present in up to 30% of minor strokes. The effectiveness of mechanical thrombectomy (MT) in the subgroup of minor stroke with LVO in the anterior circulation is still open to debate. Data about MT in this subgroup of patients are sparse, and their optimal management has not yet been defined. The purpose of this multicenter cohort study was to evaluate the effectiveness of MT in patients experiencing acute ischemic stroke (AIS) because of LVO in the anterior circulation, presenting with minor-to-mild stroke symptoms (National Institutes of Health Stroke Scale score of <8). Methods—Multicenter cohort study involving 4 comprehensive stroke centers having 2 therapeutic approaches (urgent thrombectomy associated with best medical treatment [BMT] versus BMT first and MT if worsening occurs) about management of patients with minor and mild acute ischemic stroke harboring LVO in the anterior circulation. An intention-to-treat analysis was conducted. The primary end point was the rate of excellent outcome defined as the achievement of a modified Rankin Scale score of 0 to 1 at 3 months. Results—Three hundred one patients were included, 170 with urgent MT associated with BMT, and 131 with BMT alone as first-line treatment. Patients treated with MT were younger, more often received intravenous thrombolysis, and had shorter time to imaging. Twenty-four patients (18.0%) in the medical group had rescue MT because of neurological worsening. Overall, excellent outcome was achieved in 64.5% of patients, with no difference between the 2 groups. Stratified analysis according to key subgroups did not find heterogeneity in the treatment effect size. Conclusions—Minor-to-mild stroke patients with LVO achieved excellent and favorable functional outcomes at 3 months in similar proportions between urgent MT versus delayed MT associated with BMT. There is thus an urgent need for randomized trials to define the effectiveness of MT in this patient subgroup.

10 August 2019 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
FCFederico Cagnazzo
Federico Cagnazzo
IDImad Derraz
Imad Derraz
CDCyril Dargazanli
Cyril Dargazanli
PLPierre-Henri Lefevre
Pierre-Henri Lefevre
GGGregory Gascou
Gregory Gascou
VCVincent Costalat
Vincent Costalat
Background: It is uncertain whether mechanical thrombectomy (MT) increases the probability of a good outcome (modified Rankin Scale (mRS) 0–2) in patients with Alberta Stroke Program Early CT Score (ASPECTS) 0–6.Objective: To assess the impact of MT in patients with pretreatment ASPECTS 0–6.Methods: According to PRISMA guidelines, we performed a systematic search of three databases for series of patients with ASPECTS 0–6 treated by MT. Random-effects meta-analysis was used to pool the following: rate of mRS 0–2 at 3 months follow-up, symptomatic intracranial hemorrhage (sICH), and mortality rates.Results: We included 17 studies and 1378 patients with ASPECTS 0–6 (1194 MT, 184 medical management). The rate of mRS 0–2 was 30.1% and 3.2% after MT and medical management, respectively. MT gave higher odds of mRS 0–2 (OR 4.76, p=0.01). Patients with ASPECTS 6 and 5 had comparable rates of good outcome (37.7% and 33.3%, respectively). Overall, the rate of mRS 0–2 was 17.1% in patients with ASPECTS 0–4: 22.1% and 13.9% of patients with ASPECTS 4 and 0–3 were functionally independent, respectively. Successful recanalization (Thrombolysis in Cerebral Infarction grade 2b–3) gave higher odds of mRS 0–2 than unsuccessful reperfusion (OR 5.2, p=0.001). The MT group tended to have lower odds of sICH compared with the controls (OR 0.48, p=0.06). Patients aged 70 years (40.3% vs 16.2%).Conclusions: Patients with ASPECTS 0–6may benefit from MT. Successful reperfusion increases the probability of 3-month functional independence without increasing the risk of sICH. Patients with ASPECTS 5 and 6 have comparable outcomes. MT can still enable approximately one in four patients with ASPECTS 4 to be independent, whereas only 14% of subjects with ASPECTS 0–3 regain a good functional outcome.